VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > I bet it is going to close around 0.50

<< Previous

Bullboard Posts

Next >>

Comment by Gdangiton Feb 11, 2021 4:10pm

194 Views

Post# 32543933

RE:RE:RE:RE:RE:RE:I bet it is going to close around 0.50

This company sure can survive on hype. The question is for how long. Don't you think if there was actual sales, they would be announced? Speculative stock. Why is it so hard to sell if it's Fda approved? Factory hmmmm maybe an article NR would prove it and not to mention sales. Where is this sales report that some talk about. Shouldn't sales be bragging rights to prove that the numbers are bullish?

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market